
Your Specialty Pharmacy Solutions Leader
Delivering high-touch support for complex oncology, cell and gene, and rare disease therapies.
Patients are at the heart of all we do.
Biologics is a specialty pharmacy leader that creates extraordinary experiences for oncology, cell and gene, and rare disease patients.
With over 30 years of expertise, we are committed to simplifying access to life-changing medications and delivering personalized clinical care that helps patients understand how to take their medication, manage side effects and achieve the best-possible outcomes.
How We Help
Patients
Compassionate, patient-centered care with expert clinical guidance, side-effect
management, adherence support, and financial aid.
Providers
Customized pharmacy solutions that seamlessly integrate with your workflow and elevate patient care.
Biopharma Partners
Innovative, nimble and collaborative solutions that drive access and reach to
patients.
Dan W.
Dan W. shares his cancer journey and the relationship he formed with Biologics nurse and his “guardian angel,” Porscha Scales.Larry H.
Larry H., blood cancer survivor, shares how the Biologics team helped to educate him on his therapy.Karen I.
Karen I. talks about how she was reassured by the Biologics team during her ovarian cancer journey.Teri Swepston
Teri Swepston, VP Provider Sales, shares her WHY.Now Playing

Dan W.
Now Playing

Larry H.
Now Playing

Karen I.
Now Playing

Teri Swepston
News & Stories
Biologics Drug Launches

- Biopharma
- IBTROZI
- Non-Small Cell Lung Cancer
- oncology
- RARE
- rare disease
- ROS1
- Specialty pharmacy
- taletrectinib
Cary, N.C. , June 11, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]

- AbbVie
- EMRELIS
- Non-Small Cell Lung Cancer
- rare disease
- Specialty pharmacy
- telisotuzumab vedotin-tllv)
Cary, N.C. , May 20, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]

- AVMAPKI
- avutometinib
- defactinib
- FAKZYNJA
- KRAS
- limited specialty pharmacy
- Ovarian Cancer
- RARE
Cary, N.C. , May 9, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]

- atrasentan
- Biologics
- immunoglobulin A nephropathy
- McKesson
- oncology
- RARE
- Specialty pharmacy
- VANRAFIA
CARY, N.C., April 3, 2025—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]

- GOMEKLI
- low-grade glioma
- MEK inhibitor
- mirdametinib
- neurofibromatosis
- oncology
- plexiform neurofibromas
- rare disease
- Specialty pharmacy
CARY, N.C., FEBRUARY 18, 2025—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

- oncology
- rare disease
- Romvimza
- Specialty pharmacy
- Tenosynovial Giant Cell Tumor
- vimseltinib
CARY, N.C., February 17, 2025—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia
- KMT2Amenin protein
- lysine methyltransferase 2A gene
- REVUFORJ (revumenib)
CARY, N.C., January 24, 2025—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]

- Azurity Pharmaceuticals
- Danziten
- nilotinib
- pediatric rare
- Ph+ CML
- Philadelphia chromosome
- rare disease
CARY, N.C., December 6, 2024—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

CARY, N.C., November 14, 2024—We are thrilled to announce a pivotal milestone for Biologics. As of today, we’ve gained access […]

- brain cancer
- IDH-mutant Diffuse Glioma
- VORANIGO
- vorasidenib
CARY, N.C., September 25, 2024—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected by […]

- Hutchinson-Gilford Progeria Syndrome.
- llonafarnib
- oncology
- rare disease
- Zokinvy
CARY, N.C., September 10, 2024 –Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected […]

- imetelstat
- Myelodysplastic Syndromes
- oncology
- rare disease
- RYTELO
- telomerase inhibitor
- transfusion-dependent anemia
CARY, N.C., September 9, 2024—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]

- CAMCEVI
- gonadotropin-releasing hormone (GnRH) agonist
- injection emulsion
- leuprolide
- prostate cancer
CARY, N.C., June 19, 2024—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

2025 National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo
Biologics by McKesson Specialty Pharmacy is thrilled to be a Bronze level sponsor for the National Association of Specialty Pharmacy 2025 Annual Meeting and Expo September 14 -17, 2025, at the Gaylord Rockies in Denver, CO.